IP Library Patent Application 17706102
Patent Application
App. No. 17/706,102

Systems and Methods of Sample Processing and Fluid Control in a Fluidic System

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/706,102
Abstract

This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.

Claims (34)

1 . A cartridge configured to perform an assay, comprising:

a sample collection unit configured to receive a biological fluid sample;

a metering channel configured to meter a volume of the biological fluid sample;

a mixing chamber configured to be brought into fluidic communication with the metering channel and to receive a portion of the biological fluid sample;

a reagent chamber having a volume of less than 100 microliters and including a dried reagent to be liquefied upon initiation of the assay, the reagent chamber being configured to be brought into fluid communication with the mixing chamber; and

a plurality of reaction sites in fluid communication with the reagent chamber, each reaction site comprising a reactant bound thereto and configured to generate an optical signal in response to reacting with an analyte present in the biological fluid sample.

2 . The cartridge of claim 1 , wherein the optical signals generated are detectable by a charge coupled device.

3 . The cartridge of claim 1 , wherein the optical signals generated are fluorescent signals.

4 . The cartridge of claim 1 , further comprising a fluidic channel connecting the mixing chamber and the reagent chamber.

5 . The cartridge of claim 4 , wherein the fluidic channel further comprises a burstable seal.

6 . The cartridge of claim 1 , further comprising a fluidic channel connecting the reagent chamber with the plurality of reaction sites.

7 . The cartridge of claim 6 , wherein the fluidic channel further comprises a burstable seal.

8 . The cartridge of claim 1 , further comprising:

a dilution chamber configured to receive a diluent and being configured to be brought into and out of fluidic communication with the metering channel.

9 . The cartridge of claim 1 , wherein the mixing chamber comprises a lysing assembly configured to lyse cells present in the bodily fluid sample.

10 . The cartridge of claim 9 , wherein the mixing chamber is configured to receive a diluent from a dilution chamber and receive a portion of the biological fluid sample.

11 . The cartridge of claim 10 , the mixing chamber comprising a movable mixing element configured to cause the mixing of the portion of the biological fluid sample with the diluent.

12 . The cartridge of claim 1 , the mixing chamber comprising a movable mixing element configured to mechanically mix the sample.

13 . The cartridge of claim 12 , wherein the movable mixing element is magnetically controlled.

14 . A system configured to detect an optical signal indicating the presence of an analyte in a bodily fluid sample, comprising:

a cartridge configured to perform an assay, comprising:

a sample collection unit capable of receiving the bodily fluid sample;

a metering channel configured to meter a volume of the bodily fluid sample;

a mixing chamber configured to be brought into fluidic communication with the metering channel and to receive a portion of the bodily fluid sample to be mixed;

a reagent chamber having a volume of less than 100 microliters and including a dried reagent to be liquefied upon initiation of the assay, the reagent chamber being configured to be brought into fluid communication with the mixing chamber; and

a plurality of reaction sites in fluid communication with the reagent chamber, each reaction site comprising a reactant bound thereto and configured to generate an optical signal in response to reacting with the analyte present in the bodily fluid sample; and

a reader assembly configured to receive the cartridge and configured to detect the optical signals; and

a communication assembly for transmitting said an indication that the optical signals were detected to an external device.

15 . The system of claim 14 , wherein the cartridge is configured to run a specific assay based on an assay protocol transmitted to the reader assembly from the external device, wherein a first reaction site of the plurality of reaction sites comprises a first reactant, and wherein a second reaction site of the plurality of reaction sites comprises a second reactant different from the first reactant.

16 . The system of claim 15 , wherein the assay protocol is transmitted via a wired connection from the external device.

17 . The system of claim 14 , wherein the cartridge further comprising an identifier readable by the reader assembly and configured to provide the identity of the cartridge.

18 . The system of claim 17 , wherein the assay protocol varies depending on the identifier.

19 . The system of claim 14 , wherein said system is configured to monitor more than one pharmacological parameter.

20 . The system of claim 14 , the reader assembly further comprising a charge coupled device configured to detect the optical signal.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2023
From: HOLMES, ELIZABETH; ROY, SHAUNAK; GIBBONS, IAN; QI, SHIZE DANIEL; KU, EDMOND; TODD, CHRIS; TAKAHASHI, MELISSA; JOHNSON, BRUCE; FENTON, JEFF; MORAVICK, KEITH; SPRINGBORN, UWE; DELACRUZ, ANTHONY
To: THERANOS, INC.
Reel/Frame 065130/0362 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2023
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 065130/0550 →
SECURITY INTEREST Recorded Oct 5, 2023
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 065130/0691 →
CHANGE OF NAME Recorded Oct 5, 2023
From: THERANOS IP COMPANY, LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 065131/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2023
From: LABRADOR DIAGNOSTICS LLC
To: GOLDEN DIAGNOSTICS TOP CORP.
Reel/Frame 064262/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2023
From: GOLDEN DIAGNOSTICS TOP CORP.
To: GOLDEN DIAGNOSTICS CORP.
Reel/Frame 064264/0393 →